DOI QR코드

DOI QR Code

Quality of life in gynecologic cancer survivors compared to healthy check-up women

  • Published : 2011.06.01

Abstract

Objective: The primary objective of this study was to compare quality of life of disease-free patients after therapy for gynecologic malignancies at follow-up in comparison with healthy check-up patients. Our second objective was to assess correlation between demographic data, disease and treatment factors and quality of life scores. Methods: Patients completed the Functional Assessment of Cancer Therapy-General (FACT-G) quality of life questionnaire at least 6 months after treatment for a gynecologic malignancy. Responses were compared to unmatched healthy women who were seen for standard gynecologic screening examinations. Statistical calculation was done using chi-squared tests, Wilcoxon rank-sum, and Kruskal-Wallis one-way analysis and Spearman rank correlations. Factors associated with FACT-G scores were evaluated using univariate and multivariate analyses. Results: Eight hundred and seventy patients were recruited. The median time since therapy was 61 months (range, 6 to 173 months). The overall FACT-G scores were higher in the patient group than in the healthy group (p<0.05). The scores of each subscale measuring physical, functional, social/family and emotional well-being were also higher in the patient group (p<0.05). Multivariate analysis revealed correlation between Eastern Cooperative Oncology Group performance status, educational level, care giver, presence of economic problems and FACT-G scores. Conclusion: The quality of life scores were higher in gynecologic cancer patients after treatment. And the factors that associated with the higher score in the patient group are having husband as a caregiver, no financial problem, Eastern Cooperative Oncology Group score 0 or 1 and having high school or higher education.

Keywords

References

  1. Cella DF. Measuring quality of life in palliative care. Semin Oncol 1995;22(2 Suppl 3):73-81.
  2. Kornblith A, Holland JC, editors. Handbook of measures for psychological, social and physical function in cancer. Vol. 1. Quality of life. New York: Memorial Sloan-Kettering Cancer Center; 1994.
  3. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-9. https://doi.org/10.1200/JCO.1993.11.3.570
  4. Ratanatharathorn V, Sirilerttrakul S, Jirajarus M, Silpakit C, Maneechavakajorn J, Sailamai P, et al. Quality of life, functional assessment of cancer therapy-general. J Med Assoc Thai 2001;84:1430-42.
  5. Cheson BD, McCabe MS, Phillips PH. Clinical trials. Referral resource. Clinical trials assessing quality of life. Oncology (Williston Park) 1995;9:1171-4, 1176, 1178.
  6. Miller BE, Pittman B, Case D, McQuellon RP. Quality of life after treatment for gynecologic malignancies: a pilot study in an outpatient clinic. Gynecol Oncol 2002;87:178-84. https://doi.org/10.1006/gyno.2002.6812
  7. Chan YM, Ngan HY, Li BY, Yip AM, Ng TY, Lee PW, et al. A longitudinal study on quality of life after gynecologic cancer treatment. Gynecol Oncol 2001;83:10-9. https://doi.org/10.1006/gyno.2001.6345
  8. Lutgendorf SK, Anderson B, Ullrich P, Johnsen EL, Buller RE, Sood AK, et al. Quality of life and mood in women with gynecologic cancer: a one year prospective study. Cancer 2002;94:131-40. https://doi.org/10.1002/cncr.10155
  9. Tahmasebi M, Yarandi F, Eftekhar Z, Montazeri A, Namazi H. Quality of life in gynecologic cancer patients. Asian Pac J Cancer Prev 2007;8:591-2.
  10. Awadalla AW, Ohaeri JU, Gholoum A, Khalid AO, Hamad HM, Jacob A. Factors associated with quality of life of outpatients with breast cancer and gynecologic cancers and their family caregivers: a controlled study. BMC Cancer 2007;7:102. https://doi.org/10.1186/1471-2407-7-102
  11. Carver CS, Scheier MF. Scaling back goals and recalibration of the affect system are processes in normal adaptive selfregulation: understanding 'response shift' phenomena. Soc Sci Med 2000;50:1715-22. https://doi.org/10.1016/S0277-9536(99)00412-8
  12. Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E. Prospective assessment of quality of life of female cancer patients. Gynecol Oncol 2002;85:140-7. https://doi.org/10.1006/gyno.2002.6586
  13. von Gruenigen VE, Frasure HE, Jenison EL, Hopkins MP, Gil KM. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol 2006;103:120-6. https://doi.org/10.1016/j.ygyno.2006.01.059
  14. Erekson EA, Sung VW, DiSilvestro PA, Myers DL. Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer. Int Urogynecol J Pelvic Floor Dysfunct 2009;20:159-63. https://doi.org/10.1007/s00192-008-0755-z
  15. Lai BP, Tang CS, Chung TK. Age-specific correlates of quality of life in Chinese women with cervical cancer. Support Care Cancer 2009;17:271-8. https://doi.org/10.1007/s00520-008-0473-6
  16. Wu AW. Quality-of-life assessment in clinical research: application in diverse populations. Med Care 2000;38(9 Suppl):II130-5.
  17. Cella DF, Orav EJ, Kornblith AB, Holland JC, Silberfarb PM, Lee KW, et al. Socioeconomic status and cancer survival. J Clin Oncol 1991;9:1500-9. https://doi.org/10.1200/JCO.1991.9.8.1500
  18. Gustavsson-Lilius M, Julkunen J, Hietanen P. Quality of life in cancer patients: the role of optimism, hopelessness, and partner support. Qual Life Res 2007;16:75-87. https://doi.org/10.1007/s11136-006-9101-4

Cited by

  1. Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients : A single institution experience and review of the literature vol.189, pp.6, 2013, https://doi.org/10.1007/s00066-013-0314-5
  2. Quality of Life in Ovarian Cancer Patients Choosing to Receive Salvage Chemotherapy or Palliative Treatment vol.14, pp.12, 2013, https://doi.org/10.7314/apjcp.2013.14.12.7669
  3. The correlations of sexual activity, sleep problems, emotional distress, attachment styles with quality of life: comparison between gynaecological cancer survivors and noncancer women vol.23, pp.7, 2011, https://doi.org/10.1111/jocn.12232
  4. Quality of Life in Gestational Trophoblastic Neoplasia Patients after Treatment in Thailand vol.15, pp.24, 2011, https://doi.org/10.7314/apjcp.2014.15.24.10871
  5. Quality of life among gynaecological cancer patients receiving palliative care in Kenya: A cross-sectional study vol.10, pp.1, 2011, https://doi.org/10.12968/ajmw.2016.10.1.15
  6. Cost Effectiveness Analysis of Different Management Strategies between Best Supportive Care and Second-line Chemotherapy for Platinum-resistant or Refractory Ovarian Cancer vol.17, pp.2, 2016, https://doi.org/10.7314/apjcp.2016.17.2.799
  7. Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of Thailand vol.11, pp.9, 2011, https://doi.org/10.1371/journal.pone.0163448
  8. The utility of patient reported data in a gynecologic oncology clinic vol.5, pp.None, 2018, https://doi.org/10.1186/s40661-018-0062-4
  9. Body mass index and sexual function in women with gynaecological cancer vol.28, pp.1, 2011, https://doi.org/10.1002/pon.4908
  10. Patient-reported outcomes after surgery among patients with gynecological diseases in Japan vol.42, pp.1, 2011, https://doi.org/10.1080/0167482x.2019.1708321
  11. Fear of recurrence among gynaecological cancer survivors: A qualitative study vol.31, pp.suppl2, 2011, https://doi.org/10.1016/j.enfcli.2020.12.039